Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinna

Showing results (571-580 of 595) with videos related to

Pageof 60
Sort By:
Oncotarget|February 22, 2018
Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survivalJordi Vilardell, Estefania Alcaraz, Eduard Sarró, et al.
Bioorganic & Medicinal Chemistry|December 13, 2017
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB<sub>1</sub> receptor ligand antagonistsGabriele Murineddu, Francesco Deligia, Giulio Ragusa, et al.
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Journal of Hematology & Oncology|November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicityLaura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Organic Letters|December 19, 2007
A mechanistic design principle for protein tyrosine kinase sensors: application to a validated cancer targetAya Wakata, Sean M Cahill, Michael Blumenstein, et al.
Annals of Internal Medicine|April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trialO Hartmann, A G Le Corroller, D Blaise, et al.
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Transplantation Proceedings|September 27, 2005
Kidney transplantation combined with other organs: experience of Bologna s. Orsola hospitalB Nardo, P Beltempo, R Montalti, et al.
The Biochemical Journal|May 13, 2009
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Giorgio Cozza, Marco Mazzorana, Elena Papinutto, et al.
Cellular Signalling|July 30, 2008
Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cellsGreg Vilk, Jane E Weber, Jacob P Turowec, et al.
Pageof 60

Showing results (571-580 of 595) with videos related to

Sort By:
Pageof 60
Oncotarget|February 22, 2018
Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survivalJordi Vilardell, Estefania Alcaraz, Eduard Sarró, et al.
Bioorganic & Medicinal Chemistry|December 13, 2017
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB<sub>1</sub> receptor ligand antagonistsGabriele Murineddu, Francesco Deligia, Giulio Ragusa, et al.
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Journal of Hematology & Oncology|November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicityLaura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Organic Letters|December 19, 2007
A mechanistic design principle for protein tyrosine kinase sensors: application to a validated cancer targetAya Wakata, Sean M Cahill, Michael Blumenstein, et al.
Annals of Internal Medicine|April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trialO Hartmann, A G Le Corroller, D Blaise, et al.
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Transplantation Proceedings|September 27, 2005
Kidney transplantation combined with other organs: experience of Bologna s. Orsola hospitalB Nardo, P Beltempo, R Montalti, et al.
The Biochemical Journal|May 13, 2009
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Giorgio Cozza, Marco Mazzorana, Elena Papinutto, et al.
Cellular Signalling|July 30, 2008
Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cellsGreg Vilk, Jane E Weber, Jacob P Turowec, et al.
Pageof 60